Temporal loss of En1 during limb development causes distinct phenotypes
Genes & Development · 15.04.2026
DOI: 10.1101/gad.353542.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, online erschienen am 15.04.2026. Verfasst von Alessa R Ringel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Research Group Development and Disease, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany. Hauptthemen laut MEDLINE: Homeodomain Proteins, Gene Expression Regulation, Developmental, Extremities, Phenotype. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, Deutsche Forschungsgemeinschaft, UCL.
Abstract (Originalsprache)
The precise spatiotemporal regulation of developmental genes is required for proper organogenesis. Engrailed-1 ( En1 ) is essential for dorsal–ventral patterning during mouse limb development from embryonic day 9.5 (E9.5) to E11.5. Previously, we identified the long noncoding RNA locus Maenli , which drives limb-specific En1 expression at E9.5. Here, we uncover two intergenic enhancer elements, LSEE1 & 2 , that are essential for En1 expression at E10.5 and E11.5. We demonstrate that Maenli and LSEE1&2 coordinate two transcriptional waves of En1 expression that are essential for establishing dorsal–ventral limb identity. The early wave, controlled by Maenli , is required for ventral ectoderm and apical ectodermal ridge specification, while the late wave, associated with LSEE1&2 , is critical for dorsal–ventral ectoderm specification in mouse limbs. Loss of Maenli versus LSEE1&2 results in distinct developmental phenotypes by altering the spatiotemporal expression of key genes governing axial patterning pathways. Our study underscores how temporal cis -regulatory elements modulate lineage specification and developmental patterning through shaping spatiotemporal gene function during development, representing potential candidates underpinning isolated subphenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Group Development and Disease, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany.
- Institute for Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin 13353, Germany.
- Berlin-Brandenburg Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin 13353, Germany.
- Medical Research Council Laboratory of Medical Sciences (MRC LMS), London W12 0HS, United Kingdom.
- Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London SW7 5NH, United Kingdom.
- Department of Computational Molecular Biology, Max-Planck Institute for Molecular Genetics, Berlin 14195, Germany.
ORCID-Profile: Natalia Benetti, Andreas Magg, Fabian Groll, Lars Wittler, Stephan Lorenz, George Young, Stefan Mundlos, Lila Allou
Förderung
- Medical Research Council
- Deutsche Forschungsgemeinschaft
- UCL
- Medical Research Council Laboratory of Medical Sciences
- Marie Skłodowska-Curie Actions
Zitieren
APA
Ringel, A. R., Benetti, N., Magg, A., Groll, F., Schöpflin, R., Kühnlein, M., Stiege, A. C., Fischer, U., Wittler, L., Game, L., Lorenz, S., Young, G., Mundlos, S., & Allou, L. (2026). Temporal loss of En1 during limb development causes distinct phenotypes. Genes & Development. https://doi.org/10.1101/gad.353542.125
Vancouver
Ringel AR, Benetti N, Magg A, Groll F, Schöpflin R, Kühnlein M, et al. Temporal loss of En1 during limb development causes distinct phenotypes. Genes & Development. 2026. doi:10.1101/gad.353542.125
BibTeX
@article{Ringel2026,
author = {Ringel, Alessa R and Benetti, Natalia and Magg, Andreas and Groll, Fabian and Schöpflin, Robert and Kühnlein, Mira and Stiege, Asita Carola and Fischer, Ute and Wittler, Lars and Game, Laurence and Lorenz, Stephan and Young, George and Mundlos, Stefan and Allou, Lila},
title = {Temporal loss of En1 during limb development causes distinct phenotypes},
journal = {Genes & Development},
year = {2026},
doi = {10.1101/gad.353542.125}
}
EUVIMED